

Botox for sweating is a local treatment for excessive sweating in which a medication called botulinum toxin is injected in small doses into areas where sweating is most intense.
Botulinum toxin is widely known for cosmetic procedures that reduce facial expression lines. However, the same medication may also be used to treat hyperhidrosis by temporarily reducing the nerve signals reaching the sweat glands.
The purpose of treatment is not to stop sweating throughout the entire body. Botulinum toxin reduces sweat production only in the area where it is injected. It does not destroy the sweat glands or permanently cut the nerves. Because the effect of the medication gradually wears off, sweating may return.
Botox is one of the non-surgical treatments used particularly for underarm sweating. With appropriate patient selection, it may also be considered for excessive sweating of the hands, feet, face, scalp, and localised facial sweating that occurs while eating.
Not every sweating complaint is treated directly with Botox. It must first be determined whether the sweating is primary hyperhidrosis or secondary sweating caused by another condition such as thyroid disease, low blood sugar, hormonal changes, infection, or medication use.
The word Botox is commonly used as a general term for botulinum toxin procedures. However, Botox is the brand name of a particular botulinum toxin product.
There are different types and commercial preparations of botulinum toxin. Although these products belong to the same general group, their dosage units, preparation methods, diffusion characteristics, and approved uses are not identical.
For this reason, a dose used for one product cannot be applied directly to another botulinum toxin product. The preparation and dosage should be selected by the doctor according to the treatment area and the patient’s characteristics.
The term “sweating Botox” may be used because it is easier for patients to understand. The broader and medically more accurate term is botulinum toxin treatment for hyperhidrosis.
The sweat glands are controlled by the autonomic nervous system. A chemical substance called acetylcholine is released from nerve endings and signals the sweat glands to work.
In primary hyperhidrosis, the number of sweat glands is usually normal. The problem is that these glands receive excessive nerve stimulation. Heavy sweating may occur even when the body does not need to cool down.
Botulinum toxin temporarily reduces the release of acetylcholine from nerve endings in the treated area. As a result, the signal reaching the sweat glands becomes weaker and sweat production decreases.
Botox:
Botox for sweating is therefore not a permanent treatment. However, while it remains effective, it may significantly reduce localised sweating that interferes with daily life.
Sweating is a natural mechanism that helps regulate body temperature. Completely eliminating the body’s ability to sweat would therefore be unsafe.
Botulinum toxin treatment is usually applied to a limited area of the body. Reducing sweat production in a relatively small area such as the underarms, palms, or face does not stop sweating in the rest of the body.
Many sweat glands in untreated areas continue to contribute to temperature regulation.
However, treatment should be planned carefully when large areas are treated, high total doses are required, several regions are treated at the same time, or the patient regularly performs intense physical activity in hot environments.
Athletes, people who work in hot conditions, and those who are frequently exposed to situations that raise body temperature should discuss these factors with their doctor.
Botulinum toxin may be considered in suitable patients whose localised excessive sweating significantly affects daily life.
Treatment may be considered when:
Suitability is not determined only by the amount of sweat. The effect on quality of life and the patient’s expectations are also considered.
No. Botulinum toxin is not the first or most appropriate treatment for every sweating complaint.
If sweating is caused by the following conditions, the underlying cause should be assessed first:
In secondary sweating, injecting Botox into one area does not treat the underlying problem.
For example, if thyroid disease causes generalised sweating throughout the body, the thyroid condition should be brought under control first.
Botox is more commonly used for primary focal hyperhidrosis or sweating limited to a particular area.
Primary hyperhidrosis is excessive sweating that cannot be explained by another disease or medication.
It usually:
The sweat glands are usually structurally normal in primary hyperhidrosis. Excessive nerve stimulation controlling the glands leads to increased sweating.
Botulinum toxin may temporarily reduce this nerve stimulation in the treated area.
Botulinum toxin may be used for excessive sweating in different areas of the body. However, the injection technique, dose, pain control, and risk of side effects vary by treatment area.
Underarm sweating is one of the most common areas treated with botulinum toxin for hyperhidrosis.
Underarm Botox may be considered particularly in people who:
The underarm area may be less sensitive during treatment than the palms or soles. Before the procedure, the area of most intense sweating may be identified with an iodine-starch test.
Botulinum toxin is injected into or just beneath the skin through multiple small injections. The aim is to distribute the medication evenly across the entire sweating area.
Excessive sweating of the palms may interfere with writing, using a phone or computer, shaking hands, driving, and working with delicate instruments.
Hand Botox may be considered in suitable patients who do not obtain sufficient benefit from antiperspirants or iontophoresis.
Because the palms contain many nerve endings, the injections may be painful. Local or regional anaesthesia may therefore be required.
One of the important side effects of botulinum toxin treatment for hand sweating is temporary muscle weakness. Although the medication is injected close to the sweat glands, it may affect nearby small muscles of the hand.
Temporary weakness may be noticed during activities such as:
This risk should be discussed carefully before treatment in people whose occupation depends on hand strength or precise manual skills.
Excessive sweating of the soles may cause:
The soles also contain many nerve endings, so injections may be painful. Topical anaesthetic creams may not always provide enough relief, and stronger pain-control methods may be required.
The response to foot Botox varies between individuals. The thick skin of the soles, wide treatment area, and discomfort during injections make treatment planning different from other areas.
Botox does not directly treat foot odour. However, reducing sweat may help decrease moisture and odour.
Excessive sweating of the face and scalp may be described as craniofacial hyperhidrosis.
Sweating may be particularly noticeable on the:
Facial Botox may reduce sweat production in selected patients. However, because facial muscles are involved in expression, speech, eyebrow movement, and smiling, injection points must be selected carefully.
Possible side effects in the facial area include:
The risk profile of scalp treatment may differ because facial expression muscles are less directly involved. However, the size of the area and number of injections required affect planning.
Botulinum toxin treatment for facial sweating should be performed by a physician experienced in facial anatomy and hyperhidrosis.
Facial sweating while eating is known as gustatory sweating.
Sweating during spicy or very hot meals may be a natural response. However, sweating and redness affecting a specific side of the face during nearly every meal may be associated with Frey syndrome.
Frey syndrome may develop after:
The area of food-triggered sweating may be identified using the iodine-starch test. Botulinum toxin may then be injected in small doses to reduce nerve stimulation reaching the sweat glands.
Before treatment, the doctor should determine whether the sweating is a normal reaction to food or a local nerve-related disorder.
Botulinum toxin can theoretically be injected into different sweating areas. However, treating large areas may require more injections and a higher total dose.
In broad areas such as the back, chest, abdomen, or groin:
Botulinum toxin is generally not the most practical first option for widespread body sweating. After secondary causes are investigated, oral medications or other systemic treatments may be considered.
The borders of the sweating area may not always be clearly visible. The iodine-starch test may be used to identify active sweat-producing areas, particularly in the underarms or face.
During the test:
The colour change helps map the treatment area.
The iodine-starch test does not reveal the cause of sweating. It only identifies where the sweat glands are active.
In some patients, the area is clear enough from examination and the patient’s description, so testing may not be needed.
Before treatment, the characteristics of sweating and the patient’s health are assessed.
The doctor may ask about:
Based on this assessment, the doctor plans whether Botox is appropriate, which area should be treated, and which dose should be used.
In otherwise healthy people with typical primary focal hyperhidrosis, broad blood testing may not be required solely because Botox is planned.
However, testing for secondary causes may be performed when sweating:
Depending on the symptoms, tests such as blood glucose, thyroid function, complete blood count, or other investigations may be requested.
Additional evaluation may be necessary in patients using blood-thinning medication or those with bleeding disorders.
Although the procedure varies according to the treatment area, it generally includes the following steps:
Multiple small injections may be used for underarm treatment. Pain control becomes more important for the palms and soles because these areas are more sensitive.
For facial treatment, dosage and injection points are planned more carefully to reduce the risk of affecting facial expression muscles.
The level of discomfort varies according to the treatment area.
Underarm injections are generally tolerable for most patients. Fine needles and superficial injections may reduce discomfort.
The palms and soles contain many nerve endings, so treatment in these areas may be more painful.
Pain-reducing methods may include:
The level of pain control needed for facial and scalp treatment depends on the size of the area and individual sensitivity.
The duration depends on the size of the treatment area and the number of injections.
Underarm treatment can usually be completed relatively quickly. Hand, foot, or extensive scalp treatment may take longer because of preparation, anaesthesia, and the number of injections.
An iodine-starch test or regional anaesthesia may increase the total procedure time.
Most treatments do not require hospital admission. The patient can generally return home and resume routine daily activities on the same day.
The effect of botulinum toxin does not begin fully at the moment of injection.
A reduction in sweating may be noticed within the first few days. In many patients, the effect becomes clearer within approximately one week. Full results may take one or two weeks to assess.
Continued sweating on the first day does not mean that treatment has failed.
If sufficient improvement has not occurred after approximately two weeks, the treatment area and response may be reassessed.
If sweating continues in isolated areas, the doctor decides whether additional injections are appropriate.
Botulinum toxin does not provide a permanent effect. The duration depends on the treated area, product used, dosage, and the individual characteristics of the nervous system.
In general:
Sweating may not return to its previous level immediately. As the effect wears off, nerve stimulation reaching the sweat glands gradually increases.
A new evaluation may be performed when sweating begins to interfere with daily life again.
There is no fixed repeat schedule suitable for everyone.
Treatment may be repeated when:
Treatment is not repeated unnecessarily early while the previous effect remains active. The interval depends on the product used, treatment area, and individual response.
Some patients may obtain sufficient relief with one treatment per year, while others may require assessment at shorter intervals.
Many patients continue to achieve control with repeated treatments.
However, some people may feel that the effect becomes weaker or shorter over time. Possible reasons include:
When the response becomes shorter or weaker than before, the cause should be reassessed rather than automatically increasing the dose.
Dosage units of different botulinum toxin products cannot be used interchangeably.
Compensatory sweating after endoscopic thoracic sympathetic surgery is not the same as what occurs after botulinum toxin treatment.
Botox temporarily reduces nerve signals to the sweat glands in a specific area. Because the main sympathetic nerve pathways are not cut, the classic compensatory sweating seen after surgery is not an expected major effect.
Some people may become more aware of normal sweating in untreated areas after the treated area becomes dry. This does not always mean that sweating has actually increased.
When very large areas are treated, temperature regulation and overall treatment planning should be considered separately.
Botulinum toxin may significantly reduce sweating in the treated area. In some people the area becomes almost completely dry, while in others sweating does not stop completely but decreases enough not to interfere with daily life.
Treatment success is not assessed only by complete dryness.
Improvements may include:
The goal is to reduce excessive and uncontrollable sweating rather than eliminate natural sweating completely.
Possible side effects vary according to the treated area.
General side effects may include:
These effects are usually mild and temporary.
If the medication spreads to nearby muscles, local muscle weakness may occur. This risk is particularly important in hand and facial treatment.
After underarm treatment, the following may occur:
Treatment may be postponed if there is an active infection, open wound, or significant skin disease in the underarm area.
Reducing underarm sweating may also reduce odour, but Botox is not directly an odour treatment. If odour is related to bacteria, a skin condition, or another cause, separate evaluation may be required.
The most important local risk of hand Botox is temporary muscle weakness.
The patient may experience:
These effects are generally temporary. However, they may be important for the patient’s occupation or daily activities.
Surgeons, dentists, musicians, technicians, athletes, and people who perform precise manual work should discuss these risks carefully before treatment.
Because facial muscles are located close to one another, injection points and dosage must be selected carefully.
Possible effects after facial treatment include:
The type of risk depends on the treatment area. The forehead, upper lip, area around the nose, and scalp are not treated in the same way.
Excessive dosage or inappropriate injection placement may increase the risk of affecting facial expressions.
Product information for botulinum toxin includes serious warnings about the possible spread of toxin effects beyond the injection area.
Although serious systemic spread is very rare after hyperhidrosis treatment at recommended doses, urgent medical evaluation is required if the following symptoms develop:
These symptoms may occur hours or days after treatment.
Using approved products under appropriate conditions and having the procedure performed by a physician trained in botulinum toxin treatment helps reduce risk.
Botulinum toxin may not be used in the following situations:
Some conditions are not absolute barriers but require additional assessment.
The doctor should be informed about:
The doctor should know about all medications, vitamins, and supplements being used.
Blood-thinning medications should not be stopped without medical advice merely to reduce bruising. Decisions about stopping or changing medication should be made with the prescribing physician.
Safety data regarding the use of botulinum toxin for hyperhidrosis during pregnancy and breastfeeding are limited.
Because excessive sweating is generally not an emergency condition, treatment may be postponed until after pregnancy.
The decision during breastfeeding should be based on the severity of sweating, treatment area, alternative options, and the patient’s circumstances.
Anyone who may be pregnant or is breastfeeding should inform the doctor before treatment.
Excessive sweating may significantly affect quality of life in children and adolescents. However, approved indications, age limits, and safety data vary according to the product and country.
In children, the following should first be assessed:
Treatment decisions for children and adolescents should be made by physicians experienced in this area.
The doctor’s post-treatment instructions should be followed.
General recommendations may include:
Post-treatment instructions may vary according to the treated area and product used.
The treating physician’s advice regarding showering should be followed.
A short, lukewarm shower may generally be acceptable. However, immediately after treatment it may be advisable to avoid:
If injection sites in the underarms remain tender, the doctor may specify when deodorant or antiperspirant use can resume.
Intense exercise increases body temperature and blood circulation. Heavy exercise may therefore be discouraged on the day of treatment or for a short period afterwards.
Return to sports and routine activity depends on the treatment area.
If a nerve block was used for hand or foot treatment, the affected limb should be protected until numbness has completely resolved.
Normal activity may resume after the period recommended by the doctor.
Because the full effect does not appear immediately, follow-up may be recommended.
During follow-up, the doctor may assess:
Assessment of side effects is particularly important after treatment of the hands or face.
Sweat itself generally has little noticeable smell. Odour develops when sweat interacts with bacteria on the skin.
Because botulinum toxin reduces the amount of sweat, it may help decrease moisture and odour in the underarms or feet.
However, Botox alone may not be sufficient if odour is related to:
Botulinum toxin does not physically shrink or destroy the sweat glands.
It temporarily blocks the chemical message travelling from the nerve endings to the sweat glands. As the effect wears off, communication may return and the glands continue functioning.
Surgical and energy-based treatments that permanently target sweat glands work through different mechanisms.
In primary hyperhidrosis, botulinum toxin reduces the local effect of excessive nerve stimulation. However, it does not permanently remove the tendency to develop hyperhidrosis.
In secondary sweating, it does not treat the underlying cause.
For example, Botox does not:
The type of sweating must therefore be identified correctly before treatment.
Antiperspirants are applied to the skin and temporarily block sweat ducts, reducing the amount of sweat reaching the surface.
Botulinum toxin is injected and temporarily reduces the nerve signals reaching the sweat glands.
Antiperspirants:
Botulinum toxin:
Treatment selection depends on severity, location, and previous treatments.
Iontophoresis is commonly used for hand and foot sweating. It involves passing a low electrical current through water to the skin.
Iontophoresis:
Botulinum toxin:
For hand and foot sweating, iontophoresis may often be considered before Botox. However, planning depends on the patient’s previous experience and preferences.
Oral anticholinergic medications may affect sweat glands in several parts of the body.
They may be considered for widespread sweating or sweating affecting several regions. However, they may cause systemic side effects such as:
Botulinum toxin targets only the injected area. Whole-body anticholinergic effects such as dry mouth are therefore not expected.
However, injection pain, bruising, and local muscle weakness may occur.
Endoscopic thoracic sympathetic surgery treats sympathetic nerve pathways associated with excessive sweating through the chest cavity.
Botulinum toxin:
Sympathetic surgery:
Surgery may be considered in carefully selected patients whose symptoms seriously affect quality of life and who have not benefited sufficiently from Botox or other non-surgical treatments.
Patients who benefit from botulinum toxin and accept repeat treatment may not need surgery.
However, some people may:
In these situations, other treatments and surgical options may be evaluated.
The decision for surgery is not based only on whether Botox works. The area and severity of sweating, patient age, expectations, and acceptance of the risk of compensatory sweating are also considered.
A good response to botulinum toxin does not guarantee that sympathetic surgery will provide the same result. The two treatments work through different mechanisms and have different risk profiles.
However, Botox may help a person understand how reducing sweating in a particular area affects quality of life.
A patient may be satisfied with having a dry treatment area, but compensatory sweating, which is not usually seen after Botox, may occur after surgery.
The response to Botox is therefore not the only criterion for deciding on surgery.
With appropriate patient selection, correct dosage, proper injection technique, and approved products, botulinum toxin may be an effective and generally safe treatment for hyperhidrosis.
Safety is influenced by:
Botox should not be regarded as a simple cosmetic procedure. It is a prescription medication administered by injection and should be used in a medical setting.
Botulinum toxin treatment for sweating should be performed by a physician experienced in diagnosing hyperhidrosis and administering botulinum toxin.
The initial assessment may be carried out by dermatology, internal medicine, or family medicine.
Local botulinum toxin treatment is commonly performed by dermatologists. Experience in facial anatomy is particularly important for treatment of the face and scalp.
Patients considering surgical treatment for primary hyperhidrosis may be referred to a thoracic surgeon.
The procedure should not be performed in non-medical settings where unapproved or unknown products may be used.
Mild pain, redness, and bruising may occur after treatment. However, some symptoms require medical evaluation.
The treating doctor should be contacted if there is:
Urgent medical assessment is required if difficulty swallowing, speaking, or breathing, generalised muscle weakness, or double vision develops.
Botox for sweating involves injecting botulinum toxin in small doses into areas affected by excessive sweating.
Botulinum toxin does not permanently destroy the sweat glands. It temporarily reduces the acetylcholine signal reaching the glands and suppresses sweat production in the treated area.
The treatment is particularly used for underarm sweating. With appropriate patient selection, it may also be considered for sweating of the hands, feet, face, scalp, and localised food-triggered facial sweating.
The effect generally begins during the first few days and becomes more noticeable within approximately one week. The result is not permanent, and sweating may return after several months.
Pain, bruising, and tenderness at injection sites are among the most common side effects. Temporary grip weakness may occur after hand treatment, while facial treatment may cause changes in facial expressions or asymmetry.
Botox is not suitable for every person with excessive sweating. Secondary causes should first be investigated when sweating begins suddenly, continues at night, or affects the entire body.
Treatment should be planned individually according to the location and severity of sweating, previous treatments, general health, and patient expectations.
Botox for sweating is the injection of botulinum toxin in small doses into an area affected by excessive sweating. The medication temporarily reduces nerve stimulation reaching the sweat glands and suppresses sweat production.
Botulinum toxin is most commonly used for underarm sweating. In suitable patients, it may also be used for the hands, feet, face, scalp, and localised facial sweating triggered by eating.
A reduction in sweating may begin within the first few days. A more noticeable result usually appears within approximately one week. Full response may take one or two weeks to assess.
The effect is not permanent. Although duration varies by treatment area and individual response, it generally lasts several months. Treatment may be repeated when sweating returns.
Underarm injections are tolerable for most people. Fine needles are used, and cold application or topical anaesthetic products may be used when necessary.
Temporary weakness of grip or finger movement may occur if nearby small muscles are affected. This risk should be assessed carefully in people whose occupation depends on precise hand function.
Botulinum toxin may be used for facial and scalp sweating in suitable patients. Because facial muscles control expressions, the dosage and injection points must be planned carefully.
Botulinum toxin does not surgically cut sympathetic nerve pathways, so classic compensatory sweating seen after sympathetic surgery is not an expected major side effect. Normal sweating continues in untreated areas.
Botox is a temporary, non-surgical, local treatment. Surgery may provide more permanent results but involves general anaesthesia and risks such as compensatory sweating. The most appropriate option depends on the area and severity of sweating and previous treatments.
Treatment should be performed by a physician experienced in hyperhidrosis and botulinum toxin. Local applications are commonly performed by dermatologists. Patients considering surgery may be evaluated by a thoracic surgeon.